Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Klaviyo Announces Secondary Offering of 6.5M Shares

Klaviyo, Inc. (NYSE: KVYO), a company known for its CRM tailored for B2C brands, has recently announced the launch of a proposed secondary offering of 6,500,000 shares of its Series A common stock by entities affiliated with Summit Partners, L.P. Additionally, the selling stockholders are expected to grant the underwriter a 30-day option to purchase up to an additional 975,000 shares of Series A common stock.

The offering, which is subject to market and other conditions, will not result in any proceeds for Klaviyo, Inc. The underwriter for the offering is Barclays, and the offering will be made through various means, including transactions on the New York Stock Exchange.

Klaviyo's Series A common stock was filed with the Securities and Exchange Commission (SEC) on February 19, 2025, and became effective upon filing. The offering is set to be made through a prospectus supplement and an accompanying prospectus, which can be obtained through the SEC's website or by contacting Barclays Capital Inc.

Klaviyo, known as the only CRM built for B2C brands, is powered by its built-in data platform and AI insights, combining marketing automation, analytics, and customer service into one unified solution. The company serves relationship-driven brands such as Mattel, Glossier, CorePower Yoga, Daily Harvest, and over 176,000 others.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities, nor does it indicate a sale of the securities in any state or jurisdiction where such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The market has reacted to these announcements by moving the company's shares -1.43% to a price of $31.03. For the full picture, make sure to review Klaviyo's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS